Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) are a new type of drug for the treatment of diabetes, and they have been proven to have a good hypoglycemic effect. Several lines of clinical evidence have shown that SGLT2 inhibitors can significantly reduce the risks of atherosclerosis,...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/7cdbba4d6c314a6a9f286fa7af3beceb |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|